Treatment outcomes of tuberculosis patients under directly observed therapy (DOT) for three years Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004
BCG vaccinations and primary tuberculosis at children treated in the clinic in years 1973–2002 Source: Eur Respir J 2006; 28: Suppl. 50, 857s Year: 2006
Belarus experience in video observed treatment for tuberculosis patients Source: International Congress 2019 – Tuberculosis: a public health approach Year: 2019
The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses Source: Eur Respir J 2001; 18: Suppl. 33, 473s Year: 2001
One year follow-up of T-SPOT. TB results in treated patients with active tuberculosis Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007
Surgical treatment of lung tuberculosis: our experience and results in the last 5 years Source: Eur Respir J 2005; 26: Suppl. 49, 633s Year: 2005
Empirical treatment for tuberculosis: survey of cases treated over a period of two years Source: Eur Respir J 2002; 20: Suppl. 38, 566s Year: 2002
Evaluation of new smear positive tuberculosis patients 5 years after initiation of treatment under a DOTS programme Source: Annual Congress 2010 - Tuberculosis epidemiology Year: 2010
How did the tuberculosis patients reach to a tuberculosis dispensary and how long did it take? Source: Annual Congress 2011 - Challenges in tuberculosis control Year: 2011
Comparison of two different cohorts of patients for multidrug-resistant tuberculosis treatment evaluation Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB) Year: 2006
Side effects at second line TB drugs – 2 years experience of multidrug-resistant tuberculosis department from Bucharest Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010
Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009
Directly observed therapy versus self administered therapy for patients of new smear positive pulmonary tuberculosis during hospitalisation period Source: Eur Respir J 2004; 24: Suppl. 48, 723s Year: 2004
Directly observed therapy of new revealed patients with tuberculosis in out-patient conditions Source: Eur Respir J 2003; 22: Suppl. 45, 522s Year: 2003
Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban Year: 2008
Three years of experience with a novel “virtual” pneumonia follow-up clinic Source: Eur Respir J, 50 (3) 1700703; 10.1183/13993003.00703-2017 Year: 2017
Treatment of latent tuberculosis infection with 6 months isoniazid therapy in pediatric population Source: Eur Respir J 2005; 26: Suppl. 49, 624s Year: 2005
Evaluation of drug resistance of patients with tuberculosis over a period of thirty years Source: Eur Respir J 2002; 20: Suppl. 38, 549s Year: 2002
A comparison of on-site versus remote physician follow up of directly observed preventive treatment (DOPT) for latent tuberculosis infection (LTBI) on completion rates Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012
Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience Source: Eur Respir J , 49 (3) 1602049; DOI: 10.1183/13993003.02049-2016 Year: 2017